Literature DB >> 7547035

Stable expression in Chinese hamster ovary cells of a homogeneous recombinant active fragment of human platelet glycoprotein Ib alpha.

B Schumpp-Vonach1, G Kresbach, E J Schlaeger, B Steiner.   

Abstract

A fragment (residues His1-Val289) of the alpha chain of human platelet glycoprotein Ib containing the von Willebrand factor and thrombin binding sites has been expressed in Chinese hamster ovary cells. The secreted soluble recombinant protein had an apparent molecular mass of 42 kD and reacted with a conformation-dependent monoclonal antibody that only binds to native GP Ib, thus demonstrating its proper folding. The rather broad band obtained after immobilization of the recombinant fragment on nitrocellulose could be resolved into a very sharp band of molecular weight of about 35 kD by growing the cells in the presence of tunicamycin, an inhibitor of N-linked glycosylation. The recombinant GP Ib alpha fragments (with or without glycosylation) were purified by immunoaffinity chromatography. Both truncated forms bound vWF in the presence of botrocetin with comparable affinity as a proteolytic 42 kD fragment of purified human platelet GP Ib-IX. They were also retained on thrombin-Sepharose. We then selected a cell clone (B1) that produced over at least three months about 1.5 micrograms of recombinant protein per million cells per day. Using this clone a large-scale production finally yielded milligram amounts of the functionally active recombinant human GP Ib alpha fragment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7547035     DOI: 10.1007/bf00749401

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  29 in total

Review 1.  Comparing the glycosylation patterns of recombinant glycoproteins.

Authors:  R B Parekh; T P Patel
Journal:  Trends Biotechnol       Date:  1992-08       Impact factor: 19.536

Review 2.  The platelet glycoprotein Ib-IX complex.

Authors:  Z M Ruggeri
Journal:  Prog Hemost Thromb       Date:  1991

3.  Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding.

Authors:  V Vicente; R A Houghten; Z M Ruggeri
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

4.  Structure of the human blood platelet membrane glycoprotein Ib alpha gene.

Authors:  R H Wenger; N Kieffer; A N Wicki; K J Clemetson
Journal:  Biochem Biophys Res Commun       Date:  1988-10-14       Impact factor: 3.575

5.  Glycosylation inhibitors for N-linked glycoproteins.

Authors:  A D Elbein
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding.

Authors:  M Murata; J Ware; Z M Ruggeri
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

8.  Propagation of a mouse myeloma cell line J558L producing human CD4 immunoglobulin G1.

Authors:  E J Schlaeger; B Schumpp
Journal:  J Immunol Methods       Date:  1992-01-21       Impact factor: 2.303

9.  Localization and characterization of an alpha-thrombin-binding site on platelet glycoprotein Ib alpha.

Authors:  L De Marco; M Mazzucato; A Masotti; Z M Ruggeri
Journal:  J Biol Chem       Date:  1994-03-04       Impact factor: 5.157

10.  Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells.

Authors:  R J Kaufman; L C Wasley; A J Dorner
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

View more
  1 in total

1.  Identification of a small molecule that modulates platelet glycoprotein Ib-von Willebrand factor interaction.

Authors:  Katleen Broos; Mieke Trekels; Rani Alphonsa Jose; Jonas Demeulemeester; Aline Vandenbulcke; Nele Vandeputte; Tom Venken; Brecht Egle; Wim M De Borggraeve; Hans Deckmyn; Marc De Maeyer
Journal:  J Biol Chem       Date:  2012-01-09       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.